Cargando…

Transcriptome analysis reveals effects of leukemogenic SHP2 mutations in biosynthesis of amino acids signaling

Gain-of-function mutations of SHP2, especially D61Y and E76K, lead to the development of neoplasms in hematopoietic cells. Previously, we found that SHP2-D61Y and -E76K confer HCD-57 cells cytokine-independent survival and proliferation via activation of MAPK pathway. Metabolic reprogramming is like...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yuming, Chang, Zhiguang, Hu, Bingbing, Zhang, Qi, Zhang, Dengyang, He, Chunxiao, Guo, Yao, Peng, Zhiyong, Chen, Chun, Chen, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922838/ https://www.ncbi.nlm.nih.gov/pubmed/36793607 http://dx.doi.org/10.3389/fonc.2023.1090542

Ejemplares similares

Leukemogenic SHP2 mutations lead to erythropoietin independency of HCD-57 cells: a novel model for preclinical research of SHP2-mutant JMML
por: Zhao, Yuming, et al.
Publicado: (2023)

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
por: Zhuang, Xiaomei, et al.
Publicado: (2022)

The Metabolic Signature of AML Cells Treated With Homoharringtonine
por: Zhang, Yulong, et al.
Publicado: (2022)

SHP2 participates in decidualization by activating ERK to maintain normal nuclear localization of progesterone receptor
por: Chen, Lin, et al.
Publicado: (2023)

Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
por: Zhao, Yuming, et al.
Publicado: (2021)

Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies
por: Yu, Liuting, et al.
Publicado: (2021)

Shp1 in Solid Cancers and Their Therapy
por: Varone, Alessia, et al.
Publicado: (2020)

Epidemiological studies of the leukemogenic effects of radiation.
por: Lilienfeld, A. M.
Publicado: (1966)

The Leukemogenic Action of Estrogens in Hybrid Mice
por: Gardner, W. U., et al.
Publicado: (1944)

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
por: Zhang, Haijiao, et al.
Publicado: (2017)

Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells
por: Huang, Dan, et al.
Publicado: (2023)

Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways
por: Gow, Chien-Hung, et al.
Publicado: (2014)

Using Bioinformatic Approaches to Identify Pathways Targeted by Human Leukemogens
por: Thomas, Reuben, et al.
Publicado: (2012)

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
por: Oancea, Claudia, et al.
Publicado: (2014)

Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
por: Xiao, Yan, et al.
Publicado: (2023)

Dominant-Negative Mechanism of Leukemogenic PAX5 Fusions
por: Kawamata, Norihiko, et al.
Publicado: (2011)

Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells
por: Fortin, Jerome, et al.
Publicado: (2023)

Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion
por: Zhang, Ming, et al.
Publicado: (2022)

Leukemogenic Ptpn11 Allele Causes Defective Erythropoiesis in Mice
por: Usenko, Tatiana, et al.
Publicado: (2014)

Rapid Generation of Leukemogenic Chromosomal Translocations in Vivo Using CRISPR/Cas9
por: Huang, Yun, et al.
Publicado: (2020)

Role of the Tyrosine Phosphatase SHP-2 in Mediating Adrenomedullin Proangiogenic Activity in Solid Tumors
por: Sigaud, Romain, et al.
Publicado: (2021)

Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development
por: Barbieri, Elisa, et al.
Publicado: (2016)

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
por: Ferreira, H J, et al.
Publicado: (2016)

Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
por: Zhang, Dengyang, et al.
Publicado: (2022)

Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia
por: Chen, Chiqi, et al.
Publicado: (2021)

Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish
por: Lu, J-W, et al.
Publicado: (2017)

SHP-2-induced M2 polarization of tumor associated macrophages via IL-4 regulate colorectal cancer progression
por: Li, Zhihan, et al.
Publicado: (2023)

UBE2D3 Activates SHP-2 Ubiquitination to Promote Glycolysis and Proliferation of Glioma via Regulating STAT3 Signaling Pathway
por: Pan, Zhenjiang, et al.
Publicado: (2021)

Erratum: DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
por: Ferreira, H J, et al.
Publicado: (2017)

The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG
por: Kugler, Eitan, et al.
Publicado: (2023)

Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity
por: Azran, Inbal, et al.
Publicado: (2004)

Indirect induction of radiation lymphomas in mice. Evidence for a novel, transmissible leukemogen
Publicado: (1987)

SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated SHP2 Mutations
por: Yu, Zhi-Hong, et al.
Publicado: (2014)

Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics
por: Gao, Jian, et al.
Publicado: (2022)

Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice
Publicado: (1980)

Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity
por: Weng, Stephanie, et al.
Publicado: (2016)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation
por: Pierce, Andrew, et al.
Publicado: (2012)

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
por: Massimino, Michele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3l2t2ouhro9buv5fchpk8490ve